222 related articles for article (PubMed ID: 31746365)
1. Amyloid precursor protein promotes the migration and invasion of breast cancer cells by regulating the MAPK signaling pathway.
Wu X; Chen S; Lu C
Int J Mol Med; 2020 Jan; 45(1):162-174. PubMed ID: 31746365
[TBL] [Abstract][Full Text] [Related]
2. Amyloid β precursor protein silencing attenuates epithelial‑mesenchymal transition of nasopharyngeal carcinoma cells via inhibition of the MAPK pathway.
Xu J; Ying Y; Xiong G; Lai L; Wang Q; Yang Y
Mol Med Rep; 2019 Jul; 20(1):409-416. PubMed ID: 31180550
[TBL] [Abstract][Full Text] [Related]
3. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway.
Li F; Wang J; Yan YQ; Bai CZ; Guo JQ
BMC Cancer; 2023 Dec; 23(1):1214. PubMed ID: 38066486
[TBL] [Abstract][Full Text] [Related]
4. ROR2 promotes the epithelial-mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer.
Xu J; Shi J; Tang W; Jiang P; Guo M; Zhang B; Ma G
J Cell Biochem; 2020 Oct; 121(10):4142-4153. PubMed ID: 32048761
[TBL] [Abstract][Full Text] [Related]
5. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
[TBL] [Abstract][Full Text] [Related]
6. LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway.
Liu J; Hu HB; Liu YM; Li FX; Zhang LP; Liao ZM
Mol Med Rep; 2020 Nov; 22(5):3667-3676. PubMed ID: 33000231
[TBL] [Abstract][Full Text] [Related]
7. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-β precursor protein promotes cell proliferation and motility of advanced breast cancer.
Lim S; Yoo BK; Kim HS; Gilmore HL; Lee Y; Lee HP; Kim SJ; Letterio J; Lee HG
BMC Cancer; 2014 Dec; 14():928. PubMed ID: 25491510
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib controls the epithelial‑mesenchymal transition of ovarian cancer cells via EGF and the CD44‑HA signaling pathway in a cell type‑dependent manner.
Park GB; Ko HS; Kim D
Mol Med Rep; 2017 Aug; 16(2):1826-1836. PubMed ID: 28627617
[TBL] [Abstract][Full Text] [Related]
10. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell‑derived extracellular vesicles promote the in vitro proliferation and migration of breast cancer cells through the activation of the ERK pathway.
Zhou X; Li T; Chen Y; Zhang N; Wang P; Liang Y; Long M; Liu H; Mao J; Liu Q; Sun X; Chen H
Int J Oncol; 2019 May; 54(5):1843-1852. PubMed ID: 30864702
[TBL] [Abstract][Full Text] [Related]
12. SKA2 mediates invasion and metastasis in human breast cancer via EMT.
Ren Z; Yang T; Zhang P; Liu K; Liu W; Wang P
Mol Med Rep; 2019 Jan; 19(1):515-523. PubMed ID: 30387823
[TBL] [Abstract][Full Text] [Related]
13. Astragaloside IV inhibits the invasion and metastasis of SiHa cervical cancer cells via the TGF‑β1‑mediated PI3K and MAPK pathways.
Zhang L; Zhou J; Qin X; Huang H; Nie C
Oncol Rep; 2019 May; 41(5):2975-2986. PubMed ID: 30896841
[TBL] [Abstract][Full Text] [Related]
14. Astragalus polysaccharide inhibits breast cancer cell migration and invasion by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
Yang S; Sun S; Xu W; Yu B; Wang G; Wang H
Mol Med Rep; 2020 Apr; 21(4):1819-1832. PubMed ID: 32319619
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates lncRNA H19‑induced epithelial‑mesenchymal transition in tamoxifen‑resistant breast cancer cells.
Cai J; Sun H; Zheng B; Xie M; Xu C; Zhang G; Huang X; Zhuang J
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179087
[TBL] [Abstract][Full Text] [Related]
16. Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.
Ding C; Luo J; Li L; Li S; Yang L; Pan H; Liu Q; Qin H; Chen C; Feng J
J Exp Clin Cancer Res; 2016 Jan; 35():5. PubMed ID: 26754532
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein regulates migration and metalloproteinase gene expression in prostate cancer cells.
Miyazaki T; Ikeda K; Horie-Inoue K; Inoue S
Biochem Biophys Res Commun; 2014 Sep; 452(3):828-33. PubMed ID: 25218471
[TBL] [Abstract][Full Text] [Related]
18. Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA‑induced breast cancer cell invasion via PLCγ2/PKCβ/NF‑κB/AP‑1‑dependent matrix metalloproteinase‑9 activation.
Kim JM; Park J; Noh EM; Song HK; Kang SY; Jung SH; Kim JS; Park BH; Lee YR; Youn HJ
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760219
[TBL] [Abstract][Full Text] [Related]
19. Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU.
Wang T; Gao X; Zhou K; Jiang T; Gao S; Liu P; Zuo X; Shi X
Int J Mol Med; 2020 Nov; 46(5):1683-1694. PubMed ID: 33000179
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA‑137 regulates hypoxia‑mediated migration and epithelial‑mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway.
Zhang H; Liang F; Yue J; Liu P; Wang J; Wang Z; Li H; Cheng D; Du J; Zhang K; Du P
Int J Oncol; 2020 Aug; 57(2):540-549. PubMed ID: 32626928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
